While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced that the first subject has been dosed in ...

Home remedies can complement prescribed treatments ... are key to controlling the condition in the long run. ALSO READ: Atopic dermatitis vs Contact dermatitis: Know the difference between these ...

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin is excited to announce the publication of a case study highlighting the use of ...

Aclaris Therapeutics has secured an exclusive license from Biosion for the global rights to two new antibodies.

The FDA has extended the review period for the sNDA for tapinarof cream, 1% in the treatment of atopic dermatitis.

ICP-332 is a potent and selective TYK2 inhibitor that is being developed for the treatment of various T-cell related autoimmune disorders, including atopic dermatitis (AD), vitiligo, inflammatory ...

The new PDUFA target date is March 12, 2025. The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

In one study, ChatGPT information on atopic dermatitis received a score of 3.46/5 from physicians assessing its concordance with clinical guidelines. ChatGPT treatment recommendations for atopic ...

The South San Francisco, Calif., biopharmaceutical company in May shut down two trials of zelnecirnon, which was being evaluated as a treatment for asthma and atopic dermatitis.